At the forefront of innovation: novel methods of drug delivery from Emory and Georgia TechBy Ginger Pyron | Neither of the eminent PhDs can pin down the first time they exchanged details about what each of them was investigating in the lab. But both of these researchers—the Emory Eye Center's Henry Edelhauser, former director of research, a multiple-award-winner and an acclaimed expert in drug delivery, and Mark Prausnitz, professor of chemical and
biomolecular engineering at the Georgia Institute of
Technology—are quick to cite the question that linked their interests: How can we deliver drugs to the back of the eye more efficiently and effectively?
Expanding our sphere of vision, The eye? Think bigger: The globe If
you imagined a few intrepid physicians setting up U.S.-sponsored eye clinics
in underdeveloped countries “somewhere
over there,” you’re not alone.
That visual cliche, however, is fast disappearing, thanks to community health
strategists Susan Lewallen, and Paul Courtright.
One
big question: Ten diligent years And hundreds
of people—doctors, clinical coordinators, biostatisticians, parents—who,
led by the Emory Eye Center, have been daily collecting evidence that will
answer: For an infant born with a cataract in one eye, which treatment works
best?
Beyond eye cancer: “I can" “Look what I can do!” Eager to impress, the little boy crosses his eyes. “I can do that, too.” His new friend slides one eye toward her nose. “Wow, cool! How can you move one eye and make the other one stay still?” The little girl bursts into giggles. “That eye is fake!”
The hope of watching my children grow up At age 16, with a history of night blindness and fender-benders, I got the
doctor’s verdict: “You have retinitis pigmentosa, and there’s no cure.
Start learning Braille, because by the time you’re 45, you’ll probably
be blind.” My dad immediately began raising money for vision research.
He told me, “We’re going to find a cure, Tiger.”
Eyeglasses
for Babies? Isn't that premature? Exactly The primary task for “pre-mature” babies isn’t to discern
shapes or faces, of course, but to survive their precarious fragility and
the host of problems that can accompany it. Often, though, some of those
problems affect their eyes—causing critical conditions like congenital
cataracts, myopia, corneal disorders, or retinopathy of prematurity (ROP).
Then doctors must respond quickly in order to save the child’s vulnerable
sight.
The Calhoun OakA brief history of Emory Eye Center, the Calhoun Family and a special tree